GOLDMAN SACHS GROUP INC - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 15 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$8,000
-93.6%
13,755
-83.6%
0.00%
Q1 2017$125,000
+135.8%
84,006
+724.5%
0.00%
Q3 2015$53,000
-47.5%
10,189
-19.7%
0.00%
Q2 2015$101,000
-36.5%
12,690
-26.6%
0.00%
Q1 2015$159,00017,2900.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. 4,859,885$11,955,0000.64%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 100,000$246,0000.00%
Alyeska Investment Group, L.P. 143,985$354,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 31,792$78,0000.00%
Geneva Advisors, LLC 12,500$31,0000.00%
BlackRock Investment Management, LLC 846$2,0000.00%
MORGAN STANLEY 500$1,0000.00%
BlackRock Institutional Trust Company, N.A. 28,379$70,0000.00%
Walleye Trading LLC 700$2,0000.00%
LPL Financial LLC 61,246$131,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders